S&P 500   3,377.05 (+0.49%)
DOW   28,072.65 (+1.01%)
QQQ   269.87 (-0.16%)
AAPL   446.85 (-0.90%)
MSFT   207.28 (-0.47%)
FB   265.11 (+0.80%)
GOOGL   1,507.62 (+0.72%)
AMZN   3,150.66 (+0.08%)
NVDA   443.08 (-0.79%)
CGC   17.62 (-1.73%)
BABA   252.17 (+1.62%)
TSLA   1,414.53 (-0.28%)
GE   6.86 (+2.85%)
MU   48.69 (-0.94%)
AMD   79.88 (-2.87%)
T   30.36 (+0.53%)
F   7.27 (+2.54%)
ACB   10.10 (-1.17%)
GILD   68.36 (-0.22%)
NFLX   477.47 (-1.22%)
DIS   131.29 (+1.94%)
BAC   27.32 (+2.86%)
BA   185.80 (+3.56%)
S&P 500   3,377.05 (+0.49%)
DOW   28,072.65 (+1.01%)
QQQ   269.87 (-0.16%)
AAPL   446.85 (-0.90%)
MSFT   207.28 (-0.47%)
FB   265.11 (+0.80%)
GOOGL   1,507.62 (+0.72%)
AMZN   3,150.66 (+0.08%)
NVDA   443.08 (-0.79%)
CGC   17.62 (-1.73%)
BABA   252.17 (+1.62%)
TSLA   1,414.53 (-0.28%)
GE   6.86 (+2.85%)
MU   48.69 (-0.94%)
AMD   79.88 (-2.87%)
T   30.36 (+0.53%)
F   7.27 (+2.54%)
ACB   10.10 (-1.17%)
GILD   68.36 (-0.22%)
NFLX   477.47 (-1.22%)
DIS   131.29 (+1.94%)
BAC   27.32 (+2.86%)
BA   185.80 (+3.56%)
S&P 500   3,377.05 (+0.49%)
DOW   28,072.65 (+1.01%)
QQQ   269.87 (-0.16%)
AAPL   446.85 (-0.90%)
MSFT   207.28 (-0.47%)
FB   265.11 (+0.80%)
GOOGL   1,507.62 (+0.72%)
AMZN   3,150.66 (+0.08%)
NVDA   443.08 (-0.79%)
CGC   17.62 (-1.73%)
BABA   252.17 (+1.62%)
TSLA   1,414.53 (-0.28%)
GE   6.86 (+2.85%)
MU   48.69 (-0.94%)
AMD   79.88 (-2.87%)
T   30.36 (+0.53%)
F   7.27 (+2.54%)
ACB   10.10 (-1.17%)
GILD   68.36 (-0.22%)
NFLX   477.47 (-1.22%)
DIS   131.29 (+1.94%)
BAC   27.32 (+2.86%)
BA   185.80 (+3.56%)
S&P 500   3,377.05 (+0.49%)
DOW   28,072.65 (+1.01%)
QQQ   269.87 (-0.16%)
AAPL   446.85 (-0.90%)
MSFT   207.28 (-0.47%)
FB   265.11 (+0.80%)
GOOGL   1,507.62 (+0.72%)
AMZN   3,150.66 (+0.08%)
NVDA   443.08 (-0.79%)
CGC   17.62 (-1.73%)
BABA   252.17 (+1.62%)
TSLA   1,414.53 (-0.28%)
GE   6.86 (+2.85%)
MU   48.69 (-0.94%)
AMD   79.88 (-2.87%)
T   30.36 (+0.53%)
F   7.27 (+2.54%)
ACB   10.10 (-1.17%)
GILD   68.36 (-0.22%)
NFLX   477.47 (-1.22%)
DIS   131.29 (+1.94%)
BAC   27.32 (+2.86%)
BA   185.80 (+3.56%)
Log in

OTCMKTS:PRLXParallax Health Sciences Stock Price, Forecast & News

$0.04
0.00 (0.00 %)
(As of 08/11/2020 10:47 AM ET)
Add
Compare
Today's Range
$0.04
Now: $0.04
$0.04
50-Day Range
$0.02
MA: $0.03
$0.05
52-Week Range
$0.01
Now: $0.04
$0.13
VolumeN/A
Average Volume344,120 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Parallax Health Sciences, Inc. builds and expands an integrated digital healthcare network with products and services that can provide remote communication, diagnosis, treatment, and monitoring of patients on a proprietary platform. The company offers remote healthcare products, including patent pending software and mobile apps, and other services, as well as electronic kits and devices from third-party licensed platforms that are designated towards a patient's primary health concern, such as diabetes, blood pressure, cardiovascular, general monitoring, etc.; and audio and video options that interface with the patient's healthcare providers. It also provides prescription medication dosage monitoring services; and behavioral health products comprising REBOOT, a proprietary behavioral health technology for an individual or an organization to transform the cost of treating and managing chronic illnesses that include pulmonary-COPD-asthma, diabetes, and cardiovascular diseases by effecting the modification of behavior in patients being treated for these chronic diseases. In addition, the company offers diagnostics products, which comprise Target System, a proprietary POC diagnostic immunoassay testing platform; and test cartridges for the areas of infectious diseases, cardiac markers, drugs of abuse, and various other medical conditions, as well as VT-1000 desktop analyzers, target antigen detection systems, and other products. Further, it provides SPARKS Mobile, a target system hand-held analyzer; COMPASS for behavioral modification; Fotodigm platform for remote patient monitoring, telehealth, and POC diagnostic testing services; and Intrinsic Code technology for actionable insights to behavior modification. The company was formerly known as Endeavor Power Corporation and changed its name to Parallax Health Sciences, Inc. in January 2014. Parallax Health Sciences, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.54 out of 5 stars


Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PRLX
CUSIPN/A
Phone+1-310-8994442

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees6
Next Earnings DateN/A
OptionableNot Optionable
$0.04
0.00 (0.00 %)
(As of 08/11/2020 10:47 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PRLX News and Ratings via Email

Sign-up to receive the latest news and ratings for PRLX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Parallax Health Sciences (OTCMKTS:PRLX) Frequently Asked Questions

How has Parallax Health Sciences' stock been impacted by COVID-19 (Coronavirus)?

Parallax Health Sciences' stock was trading at $0.0790 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PRLX shares have decreased by 51.9% and is now trading at $0.0380.
View which stocks have been most impacted by COVID-19
.

Has Parallax Health Sciences been receiving favorable news coverage?

Media coverage about PRLX stock has trended neutral recently, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Parallax Health Sciences earned a daily sentiment score of 0.2 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days.
View the latest news about Parallax Health Sciences
.

Are investors shorting Parallax Health Sciences?

Parallax Health Sciences saw a increase in short interest in February. As of February 15th, there was short interest totaling 4,400 shares, an increase of 29.4% from the January 31st total of 3,400 shares. Based on an average trading volume of 187,500 shares, the short-interest ratio is currently 0.0 days.
View Parallax Health Sciences' Short Interest
.

Who are some of Parallax Health Sciences' key competitors?

What other stocks do shareholders of Parallax Health Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Parallax Health Sciences investors own include Catalyst Biosciences (CBIO), Celsion (CLSN), Docusign (DOCU), Nokia Oyj (NOK), Shopify (SHOP), Tilray (TLRY), Workhorse Group (WKHS), American Airlines Group (AAL), AbbVie (ABBV) and Achillion Pharmaceuticals (ACHN).

Who are Parallax Health Sciences' key executives?

Parallax Health Sciences' management team includes the following people:
  • Ms. Calli R. Bucci, CFO, Principal Accounting Officer, Corp. Sec. & Director (Age 54)
  • Dr. David Stark, Chief Regulatory Officer
  • Mr. Paul R. Arena, CEO, Pres & Director (Age 57)
  • Mr. Nathaniel T. Bradley, CTO & Director (Age 42)

What is Parallax Health Sciences' stock symbol?

Parallax Health Sciences trades on the OTCMKTS under the ticker symbol "PRLX."

How do I buy shares of Parallax Health Sciences?

Shares of PRLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Parallax Health Sciences' stock price today?

One share of PRLX stock can currently be purchased for approximately $0.04.

What is Parallax Health Sciences' official website?

The official website for Parallax Health Sciences is www.parallaxhealthsciences.com.

How can I contact Parallax Health Sciences?

Parallax Health Sciences' mailing address is 1327 Ocean Ave Ste M, SANTA MONICA, CA 90401-1033, United States. The company can be reached via phone at +1-310-8994442.

This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.